MIAMI, Nov. 09, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Wednesday, November 14th, 2018.
“I am excited to share the significant milestones that Progressive Care and our subsidiary PharmCo have experienced in the most recent quarter with our engaged investors and the public,” said S. Parikh Mars, CEO of Progressive Care Inc. “The company is experiencing an extremely positive outlook and growth trajectory and I couldn’t be more proud of our progress in Q3 and the year to date. From record-breaking growth to the capturing of international media attention with our proprietary Tele-PharmCo platform launch, we have plenty of updates from the previous quarter to share in addition to our outlook for the remainder of the year and onward into 2019.”
In addition, interested parties have the opportunity to submit questions concerning the Company prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: email@example.com by 3:00 PM eastern standard time on Monday, November, 12th, 2018. Mr. Smith will compile a list of questions and submit them to the Company prior to the conference call. Which questions will be addressed will be based on the relevance to the shareholder base, and the question’s appropriateness in light of public disclosure rules.
To access the call:
Dial-In Number: 1-857-232-0157
Access Code: 422095
For those unable to participate in the live conference call, a replay will be available at https://smallcapvoice.com/rxmd/ shortly after the call has concluded. An archived version of the webcast will also be available https://progressivecareus.com/investor/.
For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.